GlassScriptPhysician profile
Paul A Nemcek
NPI 1861658924
$999.13
in general payments reported to CMS, 2019-2025
11 companies · $71.43 in 2025
The $71.43 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2021: $36.57 · 2022: $198 · 2023: $199 · 2024: $172 · 2025: $71.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $315.25 | 2022-2025 | Biohorizons, Biohorizons Dental Implants |
| Dentsply LLC | $296.65 | 2019 | |
| Kerr Corporation | $62.74 | 2023 | Optibond Solo Plus |
| Nobel Biocare USA | $62.74 | 2023 | Nobelactive |
| Dentsply Sirona INC | $60.55 | 2019-2023 | Cavitron |
| Biolase, INC. | $59.75 | 2022 | |
| Align Technology, INC. | $48.73 | 2022-2024 | Invisalign |
| Zimvie INC. | $47.86 | 2022 | |
| Straumann USA LLC | $18.87 | 2021 | |
| Voco America INC. | $13.74 | 2023 | Remin Pro, Admira Fusion |
| Philips North America LLC | $12.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Nemcek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.